Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Novabay Pharmaceuticals Inc shares valued at $12,929 were purchased by POPLAR POINT CAPITAL PARTNERS on Apr 03 ’25. At $0.56 per share, POPLAR POINT CAPITAL PARTNERS acquired 22,976 shares. The insider’s holdings grew to 1,015,462 shares worth approximately $2.72 million following the completion of this transaction.
Also, POPLAR POINT CAPITAL PARTNERS purchased 4,538 shares, netting a total of over 2,367 in proceeds. Following the buying of shares at $0.52 each, the insider now holds 1,020,000 shares.
Before that, POPLAR POINT CAPITAL PARTNERS had added 917 shares to its account. In a trade valued at $532, the 10% Owner bought Novabay Pharmaceuticals Inc shares for $0.58 each. Upon closing the transaction, the insider’s holdings increased to 917 shares, worth approximately $2.66 million.
As published in their initiating research note from Ladenburg Thalmann on September 18, 2019, Novabay Pharmaceuticals Inc [NBY] has been a Buy and the price target has been revised to $1.10. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in early July. As of November 15, 2017, Laidlaw has reiterated its “Buy” rating for NBY. Earlier on June 05, 2017, ROTH Capital initiated its rating. Their recommendation was “a Buy” for NBY stock.
Analyzing NBY Stock Performance
On last trading session, Novabay Pharmaceuticals Inc [AMEX: NBY] rose 17.54% to $2.68. The stock’s lowest price that day was $2.33, but it reached a high of $2.7 in the same session. During the last five days, there has been a surge of approximately 198.13%. Over the course of the year, Novabay Pharmaceuticals Inc shares have jumped approximately 442.29%. Shares of the company reached a 52-week high of $2.71 on 09/03/25 and a 52-week low of $0.46 on 04/08/25.
Support And Resistance Levels for Novabay Pharmaceuticals Inc (NBY)
According to the 24-hour chart, there is a support level at 2.44, which, if violated, would cause prices to drop to 2.19. In the upper region, resistance lies at 2.82. The next price resistance is at 2.95. RSI (Relative Strength Index) is 92.31 on the 14-day chart, showing overbought technical sentiment.
Is Novabay Pharmaceuticals Inc subject to short interest?
Stocks of Novabay Pharmaceuticals Inc saw a sharp rise in short interest on 2025-08-15 jumping by 38036.0 shares to 76296.0. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 38260.0 shares. A jump of 49.85% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.86 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.86.
